Alternative activation of macrophages in rhesus macaques (Macaca mulatta) with endometriosis

Comparative Medicine

Volumn 62, Issue 4, 2012, Pages 303-310

  Smith, Kumari A ^a,b   Pearson, Christine B ^a   Hachey, Audra M ^a   Xia, Dong Ling ^a   Wachtman, Lynn M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASE CONTROL STUDY; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; MACROPHAGE ACTIVATION; NONHUMAN; PHENOTYPE; POLARIZATION; RHESUS MONKEY;

ANIMALS; CASE-CONTROL STUDIES; CYTOKINES; ENDOMETRIOSIS; FEMALE; IMMUNOHISTOCHEMISTRY; MACACA MULATTA; MACROPHAGE ACTIVATION; MONKEY DISEASES; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 84870582336     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. 2008. The inflammatory microenvironment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 66:1-9. (Pubitemid 351324128)
2. Antsiferova YS, Sotnikova NY, Posiseeva LV, Shor AL. 2005. Changes in the T-helper cytokine profile and in lymphocyte activation at the systemic and local levels in women with endometriosis. Fertil Steril 84:1705-1711. (Pubitemid 41785668)
3. Aron-Wisnewsky J, Tordjman J, Poitou C, Darakhshan F, Hugol D, Basdevant A, Aissat A, Guerre-Millo M, Clement K. 2009. Human adipose tissue macrophages: M1 and M2 cell-surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab 94:4619-4623.
4. Bacci M, Capobianco A, Monno A, Cottone L, Di Puppo F, Camisa B, Mariani M, Brignole C, Ponzoni M, Ferrari S, Panina-Bordignon P, Manfredi AA, Rovere-Querini P. 2009. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol 175:547-556.
5. Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR, Agarwal A. 2002. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 17:426-431. (Pubitemid 34168452)
6. Berbic M, Schulke L, Markham R, Tokushige N, Russell P, Fraser IS. 2009. Macrophage expression in endometrium of women with and without endometriosis. Hum Reprod 24:325-332.
7. Cassol E, Cassetta L, Alfano M, Poli G. 2010. Macrophage polarization and HIV1 infection. J Leukoc Biol 87:599-608.
8. Chuang PC, Wu MH, Shoji Y, Tsai SJ. 2009. Downregulation of CD36 results in reduced phagocytic ability of peritoneal macrophages of women with endometriosis. J Pathol 219:232-241.
9. Daniel CR, Bostick RM, Flanders WD, Long Q, Fedirko V, Sidelnikov E, Seabrook ME. 2009. TGFα expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma. Cancer Epidemiol Biomarkers Prev 18:65-73.
10. Ferroni P, Santilli F, Guadagni F, Basili S, Davi G. 2007. Contribution of platelet-derived CD40 ligand to inflammation, thrombosis, and neoangiogenesis. Curr Med Chem 14:2170-2180. (Pubitemid 47591314)
11. Gagne D, Page M, Robitaille G, Hugo P, Gosselin D. 2003. Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum Reprod 18:1674-1680. (Pubitemid 36958049)
12. Gazvani R, Templeton A. 2002. Peritoneal environment, cytokines, and angiogenesis in the pathophysiology of endometriosis. Reproduction 123:217-226. (Pubitemid 34144671)
13. Giudice LC. 2010. Clinical practice. Endometriosis. N Engl J Med 362:2389-2398.
14. Grummer R. 2006. Animal models in endometriosis research. Hum Reprod Update 12:641-649. (Pubitemid 44288713)
15. Haber E, Danenberg HD, Koroukhov N, Ron-El R, Golomb G, Schachter M. 2009. Peritoneal macrophage depletion by liposomal bisphosphonate attenuates endometriosis in the rat model. Hum Reprod 24:398-407.
16. Hadfield RM, Yudkin PL, Coe CL, Scheffler J, Uno H, Barlow DH, Kemnitz JW, Kennedy SH. 1997. Risk factors for endometriosis in the rhesus monkey (Macaca mulatta): a case-control study. Hum Reprod Update 3:109-115. (Pubitemid 27389983)
17. Hassa H, Tanir HM, Tekin B, Kirilmaz SD, Sahin Mutlu F. 2009. Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and late-staged endometriosis. Arch Gynecol Obstet 279:891-895.
18. Hummelshoj L, Prentice A, Groothuis P. 2006. Update on endometriosis. Womens Health (Lond Engl) 2:53-56.
19. Ibrahim SO, Lillehaug JR, Johannessen AC, Liavaag PG, Nilsen R, Vasstrand EN. 1999. Expression of biomarkers (p53, transforming growth factor α, epidermal growth factor receptor, c-erbB2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas. Oral Oncol 35:302-313. (Pubitemid 29148365)
20. Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S. 1996. A novel gene, iba1, in the major histocompatibility complex class III region encoding an EF-hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 224:855-862. (Pubitemid 26278674)
21. Institute for Laboratory Animal Research. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies press.
22. Kawamura K, Komohara Y, Takaishi K, Katabuchi H, Takeya M. 2009. Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol Int 59:300-305.
23. Khan KN, Masuzaki H, Fujishita A, Kitajima M, Sekine I, Ishimaru T. 2004. Differential macrophage infiltration in early and advanced endometriosis and adjacent peritoneum. Fertil Steril 81:652-661. (Pubitemid 38376124)
24. Kohler C. 2007. Allograft inflammatory factor 1/ionized calcium-binding adapter molecule 1 is specifically expressed by most sub-populations of macrophages and spermatids in testis. Cell Tissue Res 330:291-302. (Pubitemid 47512592)
25. Krysko O, Holtappels G, Zhang N, Kubica M, Deswarte K, Derycke L, Claeys S, Hammad H, Brusselle GG, Vandenabeele P, Krysko DV, Bachert C. 2011. Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis. Allergy 66:396-403.
26. Kumar V, Bustin SA, McKay IA. 1995. Transforming growth factor α. Cell Biol Int 19:373-388.
27. Kyama CM, Debrock S, Mwenda JM, D'Hooghe TM. 2003. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol 1:123.
28. Lau SK, Chu PG, Weiss LM. 2004. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol 122:794-801. (Pubitemid 39434761)
29. Lawrence T, Natoli G. 2011. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11:750-761.
30. Ma J, Liu L, Che G, Yu N, Dai F, You Z. 2010. The M1 form of tumor-associated macrophages in non-small-cell lung cancer is positively associated with survival time. BMC Cancer 10:112.
31. Mahnke JL, Dawood MY, Huang JC. 2000. Vascular endothelial growth factor and interleukin 6 in peritoneal fluid of women with endometriosis. Fertil Steril 73:166-170. (Pubitemid 30018043)
32. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677-686. (Pubitemid 39457982)
33. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. 2002. Macrophage polarization: rumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549-555. (Pubitemid 35223554)
34. Martinez S, Garrido N, Coperias JL, Pardo F, Desco J, Garcia-Velasco JA, Simon C, Pellicer A. 2007. Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis. Hum Reprod 22:836-842.
35. Mattison JA, Ottinger MA, Powell D, Longo DL, Ingram DK. 2007. Endometriosis: clinical monitoring and treatment procedures in rhesus monkeys. J Med Primatol 36:391-398. (Pubitemid 350042178)
36. McLaren J, Prentice A, Charnock-Jones DS, Smith SK. 1996. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 11:220-223. (Pubitemid 26047702)
37. Melter M, Reinders ME, Sho M, Pal S, Geehan C, Denton MD, Mukhopadhyay D, Briscoe DM. 2000. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 96:3801-3808.
38. Mihalyi A, Gevaert O, Kyama CM, Simsa P, Pochet N, De Smet F, De Moor B, Meuleman C, Billen J, Blanckaert N, Vodolazkaia A, Fulop V, D'Hooghe TM. 2010. Noninvasive diagnosis of endometriosis based on a combined analysis of 6 plasma biomarkers. Hum Reprod 25:654-664.
39. Miura N, Kabashima H, Shimizu M, Sato R, Tsukamoto T, Harada T, Takahashi S, Endo R, Nakayama N, Takikawa Y, Mochida S, Suzuki K, Hasegawa J, Shiota G. 2008. Clinical impact of serum transforming growth factor α mRNA as a predictive biomarker for the prognosis of fulminant hepatitis. Hepatol Int 2:213-221. (Pubitemid 351650151)
40. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958-969.
41. National Institutes of Health. [Internet] 2002. Endometriosis. [Cited 05 December 2011]. Available at: http://www.nichd.nih.gov/publications/pubs/upload/ endometriosis.pdf
42. Ohri CM, Shikotra A, Green RH, Waller DA, Bradding P. 2009. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J 33:118-126.
43. Ohri CM, Shikotra A, Green RH, Waller DA, Bradding P. 2011. The tissue microlocalisation and cellular expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 is correlated to clinical outcome in NSCLC. PLoS ONE 6:e21874.
44. Oral E, Olive DL, Arici A. 1996. The peritoneal environment in endometriosis. Hum Reprod Update 2:385-398. (Pubitemid 27087175)
45. Othman ED, Hornung D, Salem HT, Khalifa EA, El-Metwally TH, Al-Hendy A. 2008. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol 137:240-246. (Pubitemid 351423457)
46. Patel JV, Lim HS, Nadar S, Tayebjee M, Hughes EA, Lip GY. 2006. Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis. J Hypertens 24:117-121. (Pubitemid 41818096)
47. Pizzo A, Salmeri FM, Ardita FV, Sofo V, Tripepi M, Marsico S. 2002. Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecol Obstet Invest 54:82-87. (Pubitemid 36164637)
48. Scarselli G, Rizzello F, Cammilli F, Ginocchini L, Coccia ME. 2005. Diagnosis and treatment of endometriosis. A review. Minerva Ginecol 57:55-78.
49. Seeber B, Sammel MD, Fan X, Gerton GL, Shaunik A, Chittams J, Barnhart KT. 2008. Panel of markers can accurately predict endometriosis in a subset of patients. Fertil Steril 89:1073-1081. (Pubitemid 351671727)
50. Setianto BY, Hartopo AB, Achadiono DN, Gharini PP. 2011. Association between levels of circulating soluble CD40 ligand on admission and in-hospital events among acute coronary syndrome patients. Acta Med Indones 43:82-87.
51. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P, Mantovani A. 2008. Macrophage polarization in tumour progression. Semin Cancer Biol 18:349-355.
52. Simms JS, Chegini N, Williams RS, Rossi AM, Dunn WA Jr. 1991. Identification of epidermal growth factor, transforming growth factor α, and epidermal growth factor receptor in surgically induced endometriosis in rats. Obstet Gynecol 78:850-857.
53. Story L, Kennedy S. 2004. Animal studies in endometriosis: a review. ILAR J 45:132-138.
54. Taylor RN, Lebovic DI, Mueller MD. 2002. Angiogenic factors in endometriosis. Ann N Y Acad Sci 955:89-100. (Pubitemid 34271066)
55. Varin A, Gordon S. 2009. Alternative activation of macrophages: immune function and cellular biology. Immunobiology 214:630-641.
56. Varin A, Mukhopadhyay S, Herbein G, Gordon S. 2010. Alternative activation of macrophages by IL4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 115:353-362.
57. Wang XQ, Yu J, Luo XZ, Shi YL, Wang Y, Wang L, Li DJ. 2010. The high level of RANTES in the ectopic milieu recruits macrophages and induces their tolerance in progression of endometriosis. J Mol Endocrinol 45:291-299.
58. Wolfe-Coote S. 2005. The laboratory primate. San Diego (CA): Academic Press.
59. Wu MY, Ho HN. 2003. The role of cytokines in endometriosis. Am J Reprod Immunol 49:285-296.
60. Yacoub D, Hachem A, Theoret JF, Gillis MA, Mourad W, Merhi Y. 2010. Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor 2/Rac1/p38 mitogen-activated protein kinase signaling pathway. Arterioscler Thromb Vasc Biol 30:2424-2433.